investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Pharmacogenetics of Phase II Drug Metabolizing Enzymes
Richard M Weinshilboum
2 Collaborator(s)
Funding source
National Institute of General Medical Sciences (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
No posts
Related projects
Thomas Sayers
Promoting Tumor Cell Apoptosis by Death Ligands
Breast
Roger D Kamm
Microfluidic 3D Assays for Metastatic Cancer
Breast
Mara A Schonberg
Breast Cancer Risk Factors Among Women Aged 75 and Older
Breast
Jeffrey J Fredberg
Epithelial layer jamming in breast cancer cell migration
Breast
Philip N Tsichlis
The role of IWS1 in development and tumorigenesis
Breast
Jeffrey Green
Transgenic Models for Prostate and Breast Cancer
Breast
Lewis A Chodosh
Minimal Residual Disease and Mechanisms of Breast Cancer Recurrence
Breast
Susan Bates
Investigation of the ABC Half-Transporter ABCG2
Breast
Fraser Symmans
Development of A Predictive Genomic Diagnostic Test for Survival Benefit from Everolimus (mTOR Inhibitor) Combined with Endocrine Therapy for Metastatic HR+/HER- Breast Cancer
Breast